Cardiology Letters 2024, 33(4):266-268
Right ventricular systolic function predicts survival in patients with cardiac amyloidosis
- School of Medicine, Comenius University and National Institute of Cardiovascular Diseases, Bratislava, Slovakia
Uverejnené: April 1, 2024 Zobraziť citáciu
Referencie
- Garcia-Pavia P, Rapezzi C, Adler Y, Arad M, Basso C, Brucato A, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2021;42:1554-1568.
Prejsť k pôvodnému zdroju... - McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599-3726. Prejsť k pôvodnému zdroju...
- Fine NM, Davis MK, Anderson K, Delgado DH, Giraldeau G, Kitchlu A, et al. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint position statement on the evaluation and management of patients with cardiac amyloidosis. Can J Cardiol. 2020;36:322-334. Prejsť k pôvodnému zdroju...
- Dispenzieri A, Gertz MA, Kyle RA, Lacy MQ, Burritt MF, Therneau TM, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis. J Clin Oncol 2004;22:3751-3757. Prejsť k pôvodnému zdroju...
- Bodez D, Ternacle J, Guellich A, Galat A, Lim P, Radu C, et al. Prognostic value of right ventricular systolic function in cardiac amyloidosis. Amyloid 2016;23:158-167. Prejsť k pôvodnému zdroju...
- Capelli F, Porciani MC, Bergesio F, Perlini S, Attanà P, Pignone MA, et al. Right ventricular function in AL amyloidosis: characteristics and prognostic implication. Eur Heart J Cardiovasc Imaging 2012;13:416-422. Prejsť k pôvodnému zdroju...
- Gilmore JD, Damy T, Fontana M, Hutchinson M, Lachmann HJ, Martinez-Naharro A, et al. A new staging system for cardiac transthyretin amyloidosis. Eur Heart J 2018;39:2799-2806. Prejsť k pôvodnému zdroju...